From Assessing Risk Factors to Understanding, Preventing, and Treating Cardiovascular Diseases: an Urgent Journey

António Heitor Reis1

  • 1University of Évora, Qta Branca do Faial, 3, 7005-862, Évora, Portugal.

Discovery Medicine
|January 5, 2023
PubMed

Insights

This study explains cardiovascular disease mechanisms, focusing on vascular lesions and apolipoprotein apoB100. It hypothesizes that KATP channels and blood pH influence coronary artery spasm and heart cell death.

Area of Science:

  • Cardiovascular Science
  • Pathophysiology
  • Molecular Cardiology

Background:

  • Cardiovascular diseases (CVDs) represent a significant global health burden.
  • Existing frameworks for understanding CVDs require further elaboration.
  • Specific molecular and physiological factors contributing to CVDs remain incompletely understood.

Purpose of the Study:

  • To expand the understanding of cardiovascular diseases within an established framework.
  • To elucidate unique distinguishing features of vascular lesions.
  • To present a rationale for the role of apolipoprotein apoB100 in CVD pathogenesis.
  • To hypothesize the involvement of KATP channels and blood pH in coronary artery spasm and cardiomyocyte death.

Main Methods:

  • Literature review and synthesis of existing published data.
  • Conceptual framework development for cardiovascular disease mechanisms.
  • Analysis of molecular pathways implicated in vascular pathology.
  • Hypothesis generation based on physiological and biochemical principles.

Main Results:

  • Detailed explanation of unique characteristics of vascular lesions.
  • Presentation of a rationale supporting the role of apolipoprotein apoB100.
  • Hypothesis positing KATP channels and blood pH as key factors in coronary artery spasm and cardiomyocyte death.
  • Integration of main cardiovascular risks within the proposed pathophysiological framework.

Conclusions:

  • The proposed framework offers a comprehensive view of cardiovascular disease development.
  • Apolipoprotein apoB100 and KATP channel regulation by blood pH are identified as critical factors.
  • Understanding these mechanisms can inform future research and therapeutic strategies for cardiovascular conditions.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
418